Skip to main content
SpringerLink
Log in

Quadruple stem cells transplantation of haploidentical bone marrow and PBSCs supporting by third-party umbilical cord blood and MSCs achieved excellent outcomes

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Data availability

The data that support the findings of this study are available from the corresponding authors on reasonable request.

References

  1. Kanakry CG, Fuchs EJ, Luznik L (2016) Modern approaches to HLA-haploidentical blood or marrow transplantation. Nat Rev Clin Oncol 13(1):10–24

    Article  CAS  PubMed  Google Scholar 

  2. van Besien K, Artz A, Champlin RE, Guarneri D, Bishop MR, Chen J et al (2019) Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning. Blood Adv 3(12):1858–1867

    Article  PubMed  PubMed Central  Google Scholar 

  3. Zhang XH, Chen J, Han MZ, Huang H, Jiang EL, Jiang M et al (2021) The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update. J Hematol Oncol 14(1):145

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ciurea SO, Al Malki MM, Kongtim P, Fuchs EJ, Luznik L, Huang XJ et al (2020) The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation. Bone Marrow Transplant 55(1):12–24

    Article  CAS  PubMed  Google Scholar 

  5. Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W et al (2006) Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Bone Marrow Transplant 38(4):291–297

    Article  PubMed  Google Scholar 

  6. Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W et al (2009) Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation. Biol Blood Marrow Transplantation : J Am Soc Blood Marrow Transplantation 15(2):257–265

    Article  CAS  Google Scholar 

  7. Burnham AJ, Daley-Bauer LP, Horwitz EM (2020) Mesenchymal stromal cells in hematopoietic cell transplantation. Blood Adv 4(22):5877–5887

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Nagler A, Labopin M, Houhou M, Aljurf M, Mousavi A, Hamladji RM et al (2021) Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. J Hematol Oncol 14(1):53

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Tsai SB, Rhodes J, Liu H, Shore T, Bishop M, Cushing MM et al (2018) Reduced-intensity allogeneic transplant for acute myeloid leukemia and myelodysplastic syndrome using combined CD34-selected haploidentical graft and a single umbilical cord unit compared with matched unrelated donor stem cells in older adults. Biol Blood Marrow Transplantation : J Am Soc Blood Marrow Transplantation 24(5):997–1004

    Article  Google Scholar 

  10. Hiwarkar P, Qasim W, Ricciardelli I, Gilmour K, Quezada S, Saudemont A et al (2015) Cord blood T cells mediate enhanced antitumor effects compared with adult peripheral blood T cells. Blood 126(26):2882–2891

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This work was partly supported by the Project from Southwest Hospital (2022DZXDX004), National Natural Science Fund of China (NSFC81800172), Project from Third Military Medical University(2021XJS15), and the Logistics Project (AWS17J007).

Author information

Author notes

  1. Chengxin Luo, Xiaohong Li, and Bei Yan contributed equally to this work.

Authors and Affiliations

  1. Center for Hematology, Southwest Hospital, Third Military Medical University, Chongqing, China

    Chengxin Luo, Dabing Qin, Xiaobo Tian, Ping Wang, Run Chen, Pei Zhang, Qiang Gong, Xi Peng, Jieping Chen & Shuangnian Xu

  2. Key Laboratory of Cancer Immunotherapy of Chongqing, Chongqing, China

    Chengxin Luo, Dabing Qin, Xiaobo Tian, Ping Wang, Run Chen, Pei Zhang, Qiang Gong, Xi Peng, Jieping Chen & Shuangnian Xu

  3. Institute of Hematology, The Fifth Medical Center, General Hospital of PLA, Beijing, China

    Xiaohong Li, Bei Yan & Xiaoxiong Wu

  4. Department of Hematology, Daping Hospital, Third Military Medical University, Chongqing, China

    Xi Li & Dongfeng Zeng

  5. Department of Hematology, The First Hospital of Jilin University, Jilin, China

    Xiaoliang Liu

  6. Department of Hematology, The 940Th Hospital of Joint Logistics Support Force of PLA, Gansu, China

    Tao Wu

Authors
  1. Chengxin Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiaohong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bei Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dabing Qin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaobo Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ping Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Run Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Pei Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Qiang Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Xi Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Xi Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Dongfeng Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Xiaoliang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Tao Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Jieping Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Xiaoxiong Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Shuangnian Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SNX and XXW designed the study and made critical revision to the manuscript; CXL, XHL, and BY collected data, performed statistical analyses, and drafted the manuscript; DBQ, XBT, PW, RC, PZ, QG, XP, XL, DFZ, XLL, TW, and JPC helped with data collection, data checking, and data interpretation. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Xiaoxiong Wu or Shuangnian Xu.

Ethics declarations

Ethics approval and consent to participate

This study was approved by Ethics Committee of Southwest Hospital, Third Military Medical University (Chongqing, China). Signed informed consent was obtained from all patients before transplantation.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Luo, C., Li, X., Yan, B. et al. Quadruple stem cells transplantation of haploidentical bone marrow and PBSCs supporting by third-party umbilical cord blood and MSCs achieved excellent outcomes. Ann Hematol 102, 3285–3287 (2023). https://doi.org/10.1007/s00277-023-05399-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-023-05399-9

Search

Navigation